The St. Louis–based robotic surgery company submitted Magic for both CE mark and FDA approval nearly a year ago; it still awaits an FDA nod in the U.S.

Magic performs cardiac ablation procedures to treat heart arrhythmia.

Stereotaxis says it designed the Magic catheter to enhance treatment precision and control during cardiac ablation while keeping the intrinsic safety advantage of a soft, flexible catheter. The design drew on nearly 20 years of insights from 150,000 robotic procedures using predecessor catheters.